Across TCGA pan-cancer cohorts, MIR204 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR204 data layer.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher MIR204 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR204 expression acts as an unfavorable survival marker, although some lineages such as SKCM and OV show a favorable association.
LIHC, UCEC, and THYM are the cancer types where MIR204 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.